This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Tsing Hua University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations in Liver Cancer Treatment by Dong-Yu Gao
Introduction
Dong-Yu Gao is a prominent inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of cancer treatment, particularly focusing on innovative methods for combating liver cancer. His work emphasizes the use of targeted nanoparticles to enhance therapeutic efficacy.
Latest Patents
Dong-Yu Gao holds a patent titled "Method for treatment of liver cancer and inhibition of metastasis with CXC-chemokine-receptor 4-targeted nanoparticle." This patent describes a method that utilizes a CXCR4 antagonist as a targeting molecule. The antagonist modifies a lipid carrier to form a nanoparticle that carries either an anti-angiogenesis drug or an anti-angiogenic nucleotide. This innovative approach enhances the accumulation and uptake of the therapeutic agents in liver cancer cells, sensitizing them to treatment. The nanoparticle effectively inhibits metastasis and provides a synergistic suppression of angiogenesis and tumor progression. The pharmaceutical composition is designed as an injectable solution, making it suitable for clinical applications in liver cancer treatment.
Career Highlights
Dong-Yu Gao is affiliated with National Tsing Hua University, where he conducts research and develops innovative solutions for cancer treatment. His work has garnered attention for its potential impact on improving patient outcomes in liver cancer therapy.
Collaborations
Dong-Yu Gao collaborates with notable colleagues, including Jia-Yu Liu and Yun-Ching Chen. Their combined expertise contributes to advancing research in targeted cancer therapies.
Conclusion
Dong-Yu Gao's innovative approach to liver cancer treatment through targeted nanoparticles represents a significant advancement in the field. His contributions are paving the way for more effective therapies that could improve the lives of patients battling liver cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile